TANG CAPITAL PARTNERS LP - Insider Non-Derivative Transactions at Jounce Therapeutics, Inc. (JNCE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 14, 2023, TANG CAPITAL PARTNERS LP's relationship to Jounce Therapeutics, Inc. (JNCE) is TenPercentOwner, and currently has 5,300,087 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other JNCE insiders.
Data Source: SEC.
TANG CAPITAL PARTNERS LP - Insider Non-Derivative Transactions of JNCE Common Stock
TANG CAPITAL PARTNERS LP - Insider Non-Derivative Transactions at JNCE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 15, 2023 | P -- (Common Stock) | 20286 | 1.02 | 5300087 |
| Mar 14, 2023 | P -- (Common Stock) | 65701 | 0.99 | 5279801 |